Texas Children's Hospital ranks #2 nationally in cancer among nation's best pediatric institutions by U.S. News & World Report
HOUSTON – (June 23, 2016) – Texas Children's Hospital has again been recognized as a national leader in cancer among pediatric hospitals by U.S. News & World Report, with Texas Children's Cancer Center ranking second nationally in their Best Children's Hospitals 2016-17 survey. To learn more about Texas Children's Cancer Center, visit txch.org and click here to watch a video.
“We are thrilled to see our expert team recognized for their commitment and passion for leading the way in delivering state-of-the-art pediatric cancer treatment and in developing innovative new therapies through our cutting-edge laboratory and clinical research efforts,” says Dr. David Poplack, director of Texas Children’s Cancer Center and professor of pediatric oncology at Baylor College of Medicine. “Our ranking further confirms our standing as a national leader in the treatment of children with cancer and our dedication to providing the most advanced care for our patients.”
Each year, U.S. News ranks pediatric hospitals overall, including ranking across 10 major subspecialties for the top 50 pediatric hospitals. These rankings are the result of a methodology that weighs a combination of outcome and care-related measures such as nursing care, advanced technology, credentialing, outcomes, best practices, infection prevention and reputation. In addition to Texas Children's Cancer Center’s #2 ranking, Texas Children's Hospital is ranked fourth among all children's hospitals nationally and is one of only 11 hospitals to achieve the Honor Roll designation by U.S. News & World Report. Texas Children's is also the only hospital in Texas – and the southern U.S. – awarded this distinction.
With a staff of renowned experts in the treatment and research of childhood cancer, Texas Children’s Cancer Center has developed a wide array of programs aimed at curing children with diagnoses ranging from the most common to the very rare.
The Center’s Precision Oncology experts are leading cutting-edge studies to understand how genome sequencing can be used to identify the unique mutations in each child’s tumor and implement more precisely-targeted, patient-specific treatments. These strategies are now also being incorporated into the pediatric cancer clinic to enable our specialists to make the most informed decisions possible for the care of each child evaluated and treated at Texas Children’s Cancer Center.
The Developmental Therapeutics and the Cell and Gene Therapy Programs have achieved national recognition as major leaders in the development of novel approaches to pediatric cancer, giving patients access to the most advanced and innovative targeted therapies, as well as cellular therapies. Working closely with referring physicians and families, appropriate options for each individual child are identified and the child and whole family are supported through the entire treatment process.
The Texas Children’s Cancer Center Rare Tumors Program is the only pediatric program of its kind in the southwest U.S. It is comprised of a multidisciplinary team of pediatric oncologists, surgeons, pathologists, geneticists, immunotherapists and other clinical researchers who work together to achieve the best outcome by developing personalized treatment regimens for even the most rare tumors of childhood.
As the largest pediatric cancer center in the country and with the incredible partnership of academic affiliate Baylor College of Medicine, Texas Children’s Cancer Center provides personalized, high-quality, family-centered care to children, adolescents and young adults with cancer. Its patients come from more than 35 states and 26 countries to receive the most advanced therapies. Physicians at Texas Children’s Cancer Center are world-renowned leaders in their field and provide state-of-the-art medical treatment for their patients.
Texas Children’s Cancer Center is also a recognized leader in clinical and laboratory research for pediatric cancer, leading the translation of break-through research findings from the laboratory into the clinic. The team is at the forefront of childhood cancer research with over 350 researchers in 42 laboratories performing cutting-edge science and conducting more clinical trials than any other pediatric cancer center in the nation.
For more information about the rankings, visit texaschildrens.org/usnews.
About Texas Children’s Hospital
Texas Children’s Hospital, a not-for-profit health care organization, is committed to creating a healthier future for children and women throughout the global community by leading in patient care, education and research. Consistently ranked as the best children’s hospital in Texas, and among the top in the nation, Texas Children’s has garnered widespread recognition for its expertise and breakthroughs in pediatric and women’s health. The hospital includes the Jan and Dan Duncan Neurological Research Institute; the Feigin Center for pediatric research; Texas Children’s Pavilion for Women, a comprehensive obstetrics/gynecology facility focusing on high-risk births; Texas Children’s Hospital West Campus, a community hospital in suburban West Houston; and Texas Children’s Hospital The Woodlands, a second community hospital planned to open in 2017. The organization also created the nation’s first HMO for children, has the largest pediatric primary care network in the country and a global health program that’s channeling care to children and women all over the world. Texas Children’s Hospital is affiliated with Baylor College of Medicine. For more information, go to www.texaschildrens.org. Get the latest news by visiting the online newsroom and Twitter at twitter.com/texaschildrens.